Atlas Trials

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer

Clinical trial NCT01202890 · TERMINATED

Trial details

NCT number
NCT01202890
Sponsor
New Mexico Cancer Research Alliance
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian CancerEpithelial Ovarian CancerFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Start date
2010-09-01
Primary completion
2011-05-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.